Fig 3.
Plot of cerebrospinal fluid (CSF) tau concentration versus CSF amyloid-β 1 to 42 peptide (Aβ1-42) concentration for the Alzheimer’s Disease Neuroimaging Initiative (ADNI) probable Alzheimer’s disease (AD; solid circles), mild cognitive impairment (MCI; squares), and elderly cognitively normal (NC; open circles) subjects.
